Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

105

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

LSD analogue with potential for treating schizophrenia

Related Posts

The neurobiology of overeating

The neurobiology of overeating

190

Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review

Inflammatory Processes in Alzheimer’s Disease—Pathomech...

126

Spatiotemporal profiling reveals the impact of caloric restriction in the aging mammalian brain

Spatiotemporal profiling reveals the impact of caloric ...

68